Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts



Related Series

CV/IR X-Ray Product Comparison Report 2014
Hybrid OR 2013
Interventional X-ray 2012
Interventional Labs 2011
Hybrid Labs Hit the Mark

Related Segments

 End chart zoom
Cardiovascular/Interventional Radiology X-ray 2008 Cardiovascular/Interventional Radiology X-ray 2008
* A page refresh may be necessary to see the updated image

Cardiovascular/Interventional Radiology X-ray 2008

August 28, 2008

As providers consider investing precious resources in x-ray equipment for cath labs and angiography suites, a number of questions are raised. Instead of purchasing separate equipment for a dedicated cath lab or IR room, can we purchase a multipurpose suite and be clinically effective for both Cardiovascular (CV) and Interventional (IR) in the same room? Can investment in this technology expand our business? With only a few vendors in this market, what are the upsides and downsides of our choices?

KLAS interviewed 90 healthcare professionals about the experiences they are having with their CV/IR x-ray equipment and vendors. The products included in this research were selected by KLAS provider partners due to the multi-role nature of the equipment in that these scanners can be used as either a cath lab, angiography suite, or in a number of other subspecialties.

Products qualifying for ranking in the study were:

  • GE Innova 3100
  • Philips Allura Xper FD20
  • Siemens Artis zee Angio

Early findings were also included for Toshiba Infinix-i Vascular.

author - Robert Ellis
Project Manager
Robert Ellis
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments